Protalix BioTherapeutics
PLX
#8916
Rank
S$0.18 B
Marketcap
S$2.24
Share price
-2.79%
Change (1 day)
-4.89%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): S$9.9 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are S$61.84 Million. In 2024 the company made an earning of S$6.72 Million a decrease over its 2023 earnings that were of S$15.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$9.9 M47.23%
2024 S$6.72 M-55.62%
2023 S$15.15 M-199.05%
2022 -S$15.31 Million-40.38%
2021 -S$25.67 Million-732.31%
2020 S$4.05 M-130.53%
2019 -S$13.3 Million189.85%
2018 -S$4.59 Million-95.29%
2017 -S$97.43 Million308.12%
2016 -S$23.88 Million-32.37%
2015 -S$35.3 Million10.11%
2014 -S$32.06 Million-7.59%
2013 -S$34.69 Million
2011 -S$40.18 Million-19.39%
2010 -S$49.84 Million20.87%
2009 -S$41.23 Million32.26%
2008 -S$31.18 Million-5.46%
2007 -S$32.98 Million
2004 -S$0.22 Million12.35%
2003 -S$0.2 Million-11.1%
2002 -S$0.22 Million-57.03%
2001 -S$0.5 Million1.03%
2000 -S$0.5 Million-53.22%
1999 -S$1.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
S$6.42 M-33.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.75 B 7,718.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.28 B 158,795.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.28 B 23,656.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel